Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001756982-20-000002
Filing Date
2020-06-10
Accepted
2020-06-10 10:54:35
Documents
1
Effectiveness Date
2020-06-10
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5710
  Complete submission text file 0001756982-20-000002.txt   6723
Mailing Address 700 MAIN STREET CAMBRIDGE MA 02139
Business Address 700 MAIN STREET CAMBRIDGE MA 02139 (857) 488-3417
Octagon Therapeutics, Inc. (Filer) CIK: 0001756982 (see all company filings)

EIN.: 815472722 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-368622 | Film No.: 20953978